Piperazine,1-acetyl-4-[3-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]non-3-yl]propyl]-

CAS No: 389887-65-4

Order 389887-65-4

Order 861390-34-3 Isooctanoyl-DL-Glutamic-α, γ-Dibutylamide

Order 766-51-8 2-Chloroanisole

Order 109-03-5 1,4-Oxathiane 4-oxide

Order 84627-04-3 Fendizoic acid

Order 757251-39-1 4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE

Order 6259-68-3 5-Amino-8-Hydroxy-[1,4]Naphthoquinone-1-Imine

Piperazine

Piperazine,

Order 202991-93-3 Piperazine,1-methyl-4-(2-pyrrolidinylmethyl)-

Order 485838-36-6 Piperazine,1-acetyl-4-[2-(5-fluoro-1H-indazol-3-yl)-1H-benzimidazol-5-yl]-

Order 485838-45-7 Piperazine,1-acetyl-4-[2-(5-ethoxy-1H-indazol-3-yl)-1H-benzimidazol-5-yl]-

Order 202991-92-2 Piperazine,1-methyl-4-(3-pyrrolidinyl)-

Order 501128-81-0 Piperazine,1-acetyl-4-[[2-cyano-7-(2,2-dimethylpropyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]methyl]-

Order 496795-65-4 Piperazine,1-acetyl-4-[[3-[[4-(2-phenyl-1H-imidazol-1-yl)-2-pyrimidinyl]amino]phenyl]methyl]-

Order 399580-61-1 Piperazine,1-(3,3,3-trifluoropropyl)-

Order 130288-91-4 Piperazine,1-(3-thienylmethyl)-

Order 485838-37-7 Piperazine,1-acetyl-4-[2-(5-chloro-1H-indazol-3-yl)-1H-benzimidazol-5-yl]-

Order 399580-57-5 Piperazine,1-(3-fluoropropyl)-

Order 66422-95-5 2, 4-Diaminophenoxyethanol Hydrochloride

Order 764-48-7 Ethylene glycol monovinyl ether

Order 36082-50-5 5-Bromo-2,4-Dichloropyrimidine

Order 90-33-5 Hymecromone

Order 1010-60-2 2-chloro-1,4-Naphthoquinone

Order 1107-00-2 2,2-Bis(3,4-anhydrodicarboxyphenyl)-hexafluoropropane(6FDA)

Order 790184-33-7 (R)-2-Methylmorpholine

Order 79-77-6 4-(2,6,6-Trimethyl-1-cyclohexenyl)-3-buten-2-one

389887-65-4 piperazine,acetyl,cyanophenoxy,hydroxypropyl,diazabicyclo,propyl,piperazine,,389887-65-4

2025-07-30 Discover Piperazine,1-acetyl-4-[3-[7-[3-(4-cyanophenoxy)-2-hydroxypropyl]-3,7-diazabicyclo[3.3.1]non-3-yl]propyl]- (CAS No: 389887-65-4) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.